Does OSIMERTINIB Cause Hypersomnia? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Hypersomnia have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.1% of all adverse event reports for OSIMERTINIB.
16
Reports of Hypersomnia with OSIMERTINIB
0.1%
of all OSIMERTINIB reports
4
Deaths
2
Hospitalizations
How Dangerous Is Hypersomnia From OSIMERTINIB?
Of the 16 reports, 4 (25.0%) resulted in death, 2 (12.5%) required hospitalization.
Is Hypersomnia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Hypersomnia?
PIMAVANSERIN (602)
ADALIMUMAB (467)
LENALIDOMIDE (401)
QUETIAPINE (394)
PREGABALIN (347)
TREPROSTINIL (317)
RISPERIDONE (302)
ARIPIPRAZOLE (286)
DULOXETINE (285)
OXYCODONE (280)
Which OSIMERTINIB Alternatives Have Lower Hypersomnia Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN